SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001213900-24-038478
Filing Date
2024-05-01
Accepted
2024-05-01 16:05:55
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0204768-s3_inmune.htm S-3 197198
2 OPINION OF SICHENZIA ROSS FERENCE CARMEL LLP ea020476801ex5-1_inmune.htm EX-5.1 20373
3 CONSENT OF MARCUM LLP ea020476801ex23-1_inmune.htm EX-23.1 2166
4 FILING FEE TABLE ea020476801ex-fee_inmune.htm EX-FILING FEES 85875
5 GRAPHIC ex5-1_001.jpg GRAPHIC 17747
  Complete submission text file 0001213900-24-038478.txt   331210
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-279036 | Film No.: 24902943
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)